Patents by Inventor Jakub Simon

Jakub Simon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HERPES SIMPLEX VIRUS NANOEMULSION VACCINES AND METHODS OF USING THE SAME
    Publication number: 20220105172
    Abstract: The present application relates to the field of human immunology, in particular, a herpes simplex virus (HSV) vaccine. The subunit vaccine composition comprises isolated surface glycoproteins from herpes simplex viruses, fusion proteins or fragments thereof mixed in varied combination with a nanoemulsion, which is a potent immune enhancer.
    Type: Application
    Filed: October 18, 2021
    Publication date: April 7, 2022
    Applicant: BlueWillow Biologics, Inc.
    Inventors: Ali I. Fattom, Jakub Simon, James R. Baker, JR., Tarek Hamouda, Vira Bitko
  • Herpes simplex virus nanoemulsion vaccine
    Patent number: 11147869
    Abstract: The present application relates to the field of human immunology, in particular, a herpes simplex virus (HSV) vaccine. The subunit vaccine composition comprises isolated surface glycoproteins from herpes simplex viruses, fusion proteins or fragments thereof mixed in varied combination with a nanoemulsion, which is a potent immune enhancer.
    Type: Grant
    Filed: November 15, 2018
    Date of Patent: October 19, 2021
    Assignee: BlueWillow Biologics, Inc.
    Inventors: Ali I. Fattom, Jakub Simon, James R. Baker, Jr., Tarek Hamouda, Vira Bitko
  • HERPES SIMPLEX VIRUS NANOEMULSION VACCINE
    Publication number: 20200197511
    Abstract: The present application relates to the field of human immunology, in particular, a herpes simplex virus (HSV) vaccine. The subunit vaccine composition comprises isolated surface glycoproteins from herpes simplex viruses, fusion proteins or fragments thereof mixed in varied combination with a nanoemulsion, which is a potent immune enhancer.
    Type: Application
    Filed: November 15, 2018
    Publication date: June 25, 2020
    Applicant: NanoBio Corporation
    Inventors: Ali I. FATTOM, Jakub Simon, James R. Baker, JR., Tarek Hamouda, Vira Bitko
  • HERPES SIMPLEX VIRUS NANOEMULSION VACCINE
    Publication number: 20190083606
    Abstract: The present application relates to the field of human immunology, in particular, a herpes simplex virus (HSV) vaccine. The subunit vaccine composition comprises isolated surface glycoproteins from herpes simplex viruses, fusion proteins or fragments thereof mixed in varied combination with a nanoemulsion, which is a potent immune enhancer.
    Type: Application
    Filed: November 15, 2018
    Publication date: March 21, 2019
    Applicant: NanoBio Corporation
    Inventors: Ali I. FATTOM, Jakub Simon, James R. Baker, JR., Tarek Hamouda, Vira Bitko
  • Herpes simplex virus nanoemulsion vaccine
    Patent number: 10206996
    Abstract: The present application relates to the field of human immunology, in particular, a herpes simplex virus (HSV) vaccine. The subunit vaccine composition comprises isolated surface glycoproteins from herpes simplex viruses, fusion proteins or fragments thereof mixed in varied combination with a nanoemulsion, which is a potent immune enhancer.
    Type: Grant
    Filed: August 22, 2012
    Date of Patent: February 19, 2019
    Assignee: NanoBio Corporation
    Inventors: Ali I. Fattom, Jakub Simon, James R. Baker, Jr., Tarek Hamouda, Vira Bitko
  • IMMUNOGENIC COMPOSITIONS COMPRISING NANOEMULSION AND METHODS OF ADMINISTERING THE SAME
    Publication number: 20140093537
    Abstract: The present invention provides methods and compositions for the stimulation of immune responses. In particular, the present invention provides immunogenic nanoemulsion compositions and methods of administering the same (e.g., via a heterologous prime/boost protocol (e.g., utilizing the same nanoemulsion in each the prime and boost administrations)) to induce immune responses (e.g., innate and/or adaptive immune responses (e.g., for generation of host immunity against an environmental pathogen)). Compositions and methods of the present invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine (e.g., vaccination)) and research applications.
    Type: Application
    Filed: September 30, 2013
    Publication date: April 3, 2014
    Applicants: NANOBIO CORPORATION, THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: James R. Baker, JR., Douglas Smith, Ali I. Fattom, Jakub Simon
  • HERPES SIMPLEX VIRUS NANOEMULSION VACCINE
    Publication number: 20130052235
    Abstract: The present application relates to the field of human immunology, in particular, a herpes simplex virus (HSV) vaccine. The subunit vaccine composition comprises isolated surface glycoproteins from herpes simplex viruses, fusion proteins or fragments thereof mixed in varied combination with a nanoemulsion, which is a potent immune enhancer.
    Type: Application
    Filed: August 22, 2012
    Publication date: February 28, 2013
    Inventors: Ali I. Fattom, Jakub Simon, James R. Baker, JR.